CL2017003040A1 - Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016). - Google Patents

Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016).

Info

Publication number
CL2017003040A1
CL2017003040A1 CL2017003040A CL2017003040A CL2017003040A1 CL 2017003040 A1 CL2017003040 A1 CL 2017003040A1 CL 2017003040 A CL2017003040 A CL 2017003040A CL 2017003040 A CL2017003040 A CL 2017003040A CL 2017003040 A1 CL2017003040 A1 CL 2017003040A1
Authority
CL
Chile
Prior art keywords
lsd1
cyclopropylamine
divisional
inhibitor
application
Prior art date
Application number
CL2017003040A
Other languages
Spanish (es)
Inventor
Wenqing Yao
Fenglei Zhang
Chunhong He
Liangxing Wu
Ding-Quan Qian
Joel R Courter
Bo Shen
Xianzhao Wang
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63046420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017003040(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of CL2017003040A1 publication Critical patent/CL2017003040A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN ESTA DIRIGIDA A LOS DERIVADOS DE LA CICLOPROPILAMINA QUE SON INHIBIDORES DE LA LSD1 EFICACES PARA EL TRATAMIENTO DE ENFERMEDADES COMO EL CÁNCER.</p><p> THIS INVENTION IS DIRECTED TO CICLOPROPILAMINE DERIVATIVES THAT ARE INHIBITORS OF THE EFFECTIVE LSD1 FOR THE TREATMENT OF DISEASES LIKE CANCER. </p>

CL2017003040A 2014-02-13 2017-11-30 Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016). CL2017003040A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462939488P 2014-02-13 2014-02-13
US201462061283P 2014-10-08 2014-10-08

Publications (1)

Publication Number Publication Date
CL2017003040A1 true CL2017003040A1 (en) 2018-04-20

Family

ID=63046420

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017003040A CL2017003040A1 (en) 2014-02-13 2017-11-30 Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016).

Country Status (1)

Country Link
CL (1) CL2017003040A1 (en)

Similar Documents

Publication Publication Date Title
ECSP16073190A (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS
CL2021000355A1 (en) Ptpn11 inhibitors
ECSP21008112A (en) PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
ECSP16073171A (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS
CL2017002483A1 (en) Heterocyclic compounds as inhibitors of lsd1
ECSP17070706A (en) BROMODOMINIUM INHIBITORS
NI201600165A (en) LYSINE-SPECIFIC DESMETILASE 1 INHIBITORS
MX394062B (en) METHODS FOR THE TREATMENT OF OVARIAN CANCER.
TW201613860A (en) Cyclopropylamines as LSD1 inhibitors
CO2017009298A2 (en) Alpha-cinnamide compounds and compositions as hdac8 inhibitors
CR20150517A (en) PHD INHIBITORS OF 6- (5-HYDROXI-1H-PIRAZOL-1-IL) NICOTINAMIDE
MX2017008179A (en) PROCESS FOR THE PREPARATION OF A DIARILTIOHIDANTOINE COMPOUND.
CR20200464A (en) DIOLIC AMINOPYRAZINE COMPOUNDS AS PI3K-Y INHIBITORS
MX2017001352A (en) PIRROLIDINONE DERIVATIVES AS INHIBITORS OF METIONIN AMINOPEPTIDASE 2 (METAP-2).
NI201801172A (en) NEW COMPOUNDS FOR THE TREATMENT OF PARASITIC DISEASES
MX2019012734A (en) Processes for the preparation of a diarylthiohydantoin compound.
MX369857B (en) Pyrazines modulators of gpr6.
CL2017003040A1 (en) Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016).
SV2017005392A (en) CRYSTAL BASE INHIBITORS